Medtronic, IBM Watson unveil predictive diabetes app
The CEOs of Medtronic (NYSE:MDT) and International Business Machine (NYSE:IBM) yesterday unveiled a the fruits of the project they’ve been working on since last April, combining the IBM Watson...
View ArticleIvenix taps ex-GI Dynamics chief Randle for CEO | Personnel Moves
Ivenix said in named former GI Dynamics (ASX:GID) chief Stuart Randle to be its new CEO. Randle departed GI Dynamics in August 2014, after 10 years with the bariatric device maker. Amesbury,...
View ArticleGlobus Medical ticks up as Q4 prelims beat expectations
Shares of Globus Medical (NYSE:GMED) ticked up nearly 2% yesterday after the orthopedic implant maker reported preliminary 4th-quarter results that topped expectations. Audubon, Pa.-based Globus said...
View ArticlePA rep Fitzpatrick wants FDA to launch criminal probe into morcellator deaths
Rep. Mike Fitzpatrick (R-Pa.) wants the FDA to open a criminal investigation of several deaths associated with laparoscopic power morcellators used during surgeries to remove ostensibly benign uterine...
View ArticleGOP tilts at the windmill again: House votes once more to repeal Obamacare
(Reuters) — The U.S. Congress yesterday approved legislation dismantling President Barack Obama’s signature healthcare plan, putting on his desk an election-year measure that faces a certain veto....
View ArticlePrecision Coating, Kisco pick up coating companies
Coating companies are on the acquisition menu for the week, with both Precision Coating and Kisco announcing new acquisitions of coating application companies yesterday. Boston-based Precision Coating...
View ArticleNeuroMetrix jumps on next-gen Quell FDA nod, but can’t hold momentum
NeuroMetrix (NSDQ:NURO) saw shares jump as high as 37% yesterday after announcing it won FDA 510(k) clearance for an upgraded version of its Quell wearable over-the-counter chronic pain relief device,...
View ArticlePi-Cardia pulls in $10m for Leaflex aortic valve catheter
Stalthy Pi-Cardia said today that it raised $10 million from a consortium that includes a mystery strategic investor for its Leaflex treatment for aortic stenosis. Rehovot, Israel-based Pi-Cardia’s...
View ArticleFDA clears Glaukos Phase II iDose drug-eluting eye implant trial
Glaukos (NYSE:GKOS) said today it won a nod from the FDA for an investigational new drug Phase II study of its Travoprost intraocular implant utilizing the company’s iDose delivery system for patients...
View ArticleCardica, Intuitive Surgical re-up licensing deal
Cardica (NSDQ:CRDC) said today that it re-upped a licensing deal with Intuitive Surgical (NSDQ:ISRG) to include the evaluation and possible development of a cartridge stapler for Intuitive’s da Vinci...
View ArticleXcede reaches out to Cook Biotech for hemostatic patch development
Dynasil subsidiary Xcede Technologies said yesterday it inked collaborative development, licensing and supply agreements with Cook Medical‘s Biotech biz to aid in the development and regulatory...
View ArticleMST wins FDA nod for robotic surgery software
Robotic surgical software developer Medical Surgery Technologies said yesterday it won FDA 510(k) clearance for its Follow Me minimally invasive robotic surgery software. The Follow Me software is...
View ArticleUpdate: Penumbra launches POD packing coil
Update: Added comments from Penumbra CEO Adam Elsesser Penumbra (NYSE:PEN) yesterday launched its POD packing coil in the U.S., designed as a complimentary addition to the company’s Ruby and POD...
View ArticleMassDevice.com +3 | The top 3 medtech stories for January 7, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleInsightec pulls in $22m, taps board chair Ferré as CEO
Insightec said today it secured a $22 million investment and tapped Dr. Maurice Ferré as its new CEO, with former CEO Kobi Vortman stepping down and taking a seat on the board. The $22 million comes...
View ArticleFDA clears Integra’s Omnigraft for treating diabetic foot ulcers
Integra LifeSciences (NSDQ:IART) said today it won expanded FDA approval for its Omnigraft dermal regeneration matrix, now indicated to treat diabetic foot ulcers. The device, made of silicone, cow...
View ArticleSinocare closes $273m Nipro buy
Nipro (TYO: 8086) said today it closed the $273 million sale of its diagnostics business to China-based Sinocare, which renamed the newly acquired company to Trividia Health. Former Nipro Diagnostics...
View ArticleSpecialty plastic manufacturer Pexco acquires Scientific Plastics Corporation
Specialty plastic manufacturer Pexco said today it acquired St. Paul, Minn.-based Scientific Plastics Corporation for an undisclosed amount. Scientific Plastics Corp is a dual-certified ISO 9001 and...
View ArticleBoston Children’s CIO discusses digital health, innovation and collaboration
During the last decade or so, health care has been rapidly transforming from a reactive, paper-based system to a responsive digital model. Massachusetts, under Gov. Charlie Baker’s leadership, has...
View ArticleBard to shutter ex-Rochester Medical plants in Minnesota, laying off 185
C.R. Bard (NYSE:BCR) reportedly plans to shutter a trio of Bard Medical plants in Minnesota by the end of the year, meaning layoffs for the 185 workers employed there. “We understand that our employees...
View Article
More Pages to Explore .....